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Introduction
Noninvasive ventilation (NIV) represents the standard of
care for patients with exacerbation of chronic obstruc-
tive pulmonary disease. However, NIV fails in almost
40% of the most severe forms of acute hypercapnic
respiratory failure and patients must undergo endotra-
cheal intubation and invasive ventilation. Such transition
from NIV to invasive ventilation is associated to
increased mortality. Under these circumstances, patients
may express a clear intention not to be intubated.
Objectives
To assess efficacy and safety of noninvasive ventilation-
plus-extracorporeal Co2 removal in patients who fail
NIV and refuse endotracheal intubation.
Methods
We reported data from a case series of 30 patients with
acute hypercapnic respiratory failure due to exacerbation
of chronic obstructive pulmonary disease, who refused
endotracheal intubation after failing NIV and therefore
were treated with extracorporeal Co2 removal plus NIV
as last resort therapy. All patients acknowledged the
nature of last resort therapy and gave consent to treat-
ment. Collected data of these patients were then retro-
spectively matched with data obtained from 30 historical
controls who received conventional treatment with
endotracheal intubation.
Results
After matching the patients, demographic characteristics
including age, BMI, gender and SOFA II score did not
differ between the two study groups. At the baseline, 20
patients in the treated group and 16 in the control
group required norepinephrine to maintain mean arter-
ial pressure, at the doses of 0.46 ± 0.18 and 0.37 ± 0.15
(mean ± SD) µg/Kg/min respectively, without statisti-
cally significant differences.A significant reduction of
PaCo2 from baseline to 96 hours of treatment was
observed in both group (p < 0.05) and reached between
groups difference only at 24 hours. An increase in arter-
ial pH were observed from baseline to 96 hours of treat-
ment in both groups (p < 0.05) and between groups
difference was observed at 96 hours (p < 0.004, Fig 1
and 2). The duration of extracorporeal Co2 removal was
4.8 ± 3 (mean ± SD) days. The longer duration of treat-
ment was 16 days. At day 14, the percentage of patients
requiring norepinephrine was lower in the treated group
compared to the control group, 30 % vs. 60 % respectively
(p = 0.04). Mortality at day 28 was significantly lower in
the treated group than in control group (23.3 % vs. 58.1 %,
p < 0.001, Fig 3). In the treated group none of patients
experienced bleeding events with a heparin infusion in the
circuit of 5.6 ± 1.5 (mean ± SD) UI/Kg/h. Nevertheless
8 patients had clots in the circuit which required the sub-
stitution of the circuit.
Conclusions
Our results support the need for a large randomized
controlled clinical trial to test the hypothesis that extra-
corporeal Co2 removal may contribute to improve survi-
val in patients with acute hypercapnic respiratory failure
due to exacerbation of chronic obstructive pulmonary
disease.
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